Sec Form 4 Filing - Lane Michael @ IDEXX LABORATORIES INC /DE - 2021-02-14

Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security.

Form 4: Statement of changes in beneficial ownership, filed before the end of the 2nd business day following the day on which a transaction resulting in a change in beneficial ownership.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Lane Michael
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Executive Vice President
(Last)
(First)
(Middle)
C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
02/14/2021
(Street)
WESTBROOK, ME04092
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/14/2021 M 221 A $ 0 4,005 ( 1 ) D
Common Stock 02/14/2021 M 212 A $ 0 4,217 D
Common Stock 02/14/2021 M 196 A $ 0 4,413 D
Common Stock 02/14/2021 M 181 A $ 0 4,594 D
Common Stock 02/14/2021 M 174 A $ 0 4,768 D
Common Stock 02/14/2021 F 314 D $ 544.08 4,474 D
Common Stock 02/16/2021 S 850 D $ 545 3,624 D
Common Stock 592 ( 2 ) I by spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy) $ 544.08 ( 3 ) 02/14/2021 A 6,003 ( 4 ) 02/13/2031 Common Stock 6,003 ( 12 ) 6,003 D
Incentive Stock Option (right-to-buy) $ 544.08 ( 3 ) 02/14/2021 A 183 ( 5 ) 02/13/2031 Common Stock 183 ( 12 ) 183 D
Restricted Stock Unit ( 6 ) 02/14/2021 A 643 ( 6 ) ( 6 ) Common Stock 643 ( 12 ) 3,292 D
Restricted Stock Unit ( 7 ) 02/14/2021 M 221 ( 7 ) ( 7 ) Common Stock 221 ( 12 ) 3,071 D
Restricted Stock Unit ( 8 ) 02/14/2021 M 212 ( 8 ) ( 8 ) Common Stock 212 ( 12 ) 2,859 D
Restricted Stock Unit ( 9 ) 02/14/2021 M 196 ( 9 ) ( 9 ) Common Stock 196 ( 12 ) 2,663 D
Restricted Stock Unit ( 10 ) 02/14/2021 M 181 ( 10 ) ( 10 ) Common Stock 181 ( 12 ) 2,482 D
Restricted Stock Unit ( 11 ) 02/14/2021 M 174 ( 11 ) ( 11 ) Common Stock 174 ( 12 ) 2,308 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Lane Michael
C/O IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK, ME04092
Executive Vice President
Signatures
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane 02/17/2021
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
( 2 )Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
( 3 )Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
( 4 )Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
( 5 )Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
( 6 )Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
( 7 )Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
( 8 )Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
( 9 )Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
( 10 )Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
( 11 )Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
( 12 )Not applicable.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.